| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.700 | None | 0.976 | 16 | 0 | 1989 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.979 | 7 | 0 | 1989 | 2020 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.600 | None | 0.990 | 28 | 0 | 2007 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.600 | None | 0.986 | 4 | 0 | 2002 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.600 | None | 0.962 | 2 | 0 | 2006 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.957 | 2 | 0 | 1994 | 2020 | ||||||||
|
checkpoint with forkhead and ring finger domains | 0.633 | 0.500 | 7.9E-04 |
|
disease | 0.550 | None | 0.800 | 1 | 0 | 2008 | 2015 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.470 | None | 0.875 | 1 | 0 | 2012 | 2019 | ||||||||
|
EMAP like 4 | 0.569 | 0.577 | 4.8E-04 |
|
disease | 0.400 | None | 0.994 | 6 | 0 | 2007 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.972 | 4 | 0 | 1990 | 2020 | ||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
disease | 0.400 | None | 0.989 | 4 | 0 | 2009 | 2020 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2008 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.917 | 2 | 0 | 1999 | 2020 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2019 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.400 | None | 0.963 | 2 | 0 | 2002 | 2020 | ||||||||
|
microRNA 126 | 0.447 | 0.846 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2008 | 2020 | |||||||||
|
enolase 2 | 0.475 | 0.846 | 0.38 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2020 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1997 | 2017 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.400 | None | 0.914 | 1 | 0 | 2005 | 2019 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.964 | 1 | 0 | 1996 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
microRNA 205 | 0.482 | 0.846 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2008 | 2019 |